Early diagnosis of patients carrying biallelic RFC1 expansions, when the sensory neuropathy is still isolated, is crucial both for ensuring optimal patient management and for tracking the full natural history of the disease, including its early stages, when the neurodegenerative processes will likely be more amenable to therapeutic interventions.27 Here, RFC1 is linked to sensory peripheral neuropathy.